Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Ascletis Adds Support to $100 Million in Startup Capital

publication date: Jul 21, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Ascletis, a US-China drug development startup, announced new support from the two cities in which it will do business – Hangzhou, China, and Research Triangle Park, US. One feature of the new agreements is clear: Ascletis will house a US-based R&D center in the Research Triangle’s Hamner Institutes. Beyond that, there aren’t many specifics in the agreements, beyond access to the networks of The Hamner and Hangzhou Hi-Tech Industry Development Zone. More details....

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...